Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

No longer available 1Completed 1

Sponsor Class

OTHER 6INDUSTRY 2

Study Type

Interventional 1Expanded_access 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Fibrosis 2Carcinoma, Hepatocellular 2Liver Cirrhosis 1Hepatitis D 1Hepatitis B, Chronic 1Hepatitis B 1Esophageal and Gastric Varices 1

Interventions

Sorafenib 79pembrolizumab 37Bevacizumab 36Nivolumab 33lenvatinib 30atezolizumab 24durvalumab 17Oxaliplatin 12Ipilimumab 12regorafenib 9Capecitabine 9tremelimumab 8Injections 8Doxorubicin 8tislelizumab 7sintilimab 7Fluorouracil 7cabozantinib 6budigalimab 6brivanib 6Ramucirumab 6toripalimab 5Gemcitabine 5Everolimus 5Cyclophosphamide 5ADI PEG20 5fludarabine 4Sunitinib 4Leucovorin 4E-7386 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Carcinoma, Hepatocellular × Tenofovir × Clear all
NCT05683548 2025-02-17

RCAP

Replicor Inc.

No longer available
Gastrointestinal

Hepatitis D, Esophageal and Gastric Varices, Fibrosis, Hepatitis B, Carcinoma, Hepatocellular, Liver Cirrhosis

NCT02224456 2022-02-14

Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis

GlaxoSmithKline

Phase 4 Completed
197 enrolled 27 charts
Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Hepatitis B, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡